MiNK Therapeutics, Inc.
INKTNasdaqCIK 1840229HealthcareFiscal year ends Dec 31
Reports and events: 71 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1320:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-349309 |
| 2026-08-1311:40 ET | 8-K | 2.02 Results of operations | 0001193125-26-347907 |
| 2026-06-2314:09 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-278642 |
| 2026-05-1520:16 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-226804 |
| 2026-05-1512:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-225369 |
| 2026-04-3020:38 ET | DEF 14A | Proxy statementPeriod 2026-06-17 | 0001193125-26-197577 |
| 2026-03-3120:49 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-134813 |
| 2026-03-3112:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-133346 |
| 2026-03-2714:40 ET | 8-K | 8.01 Other events | 0001193125-26-127931 |
| 2026-03-1921:21 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-116219 |
| 2026-01-0221:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-000916 |
| 2025-12-0821:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-311229 |
| 2025-11-1421:05 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-282905 |
| 2025-09-2913:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-221863 |
| 2025-08-1420:17 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-108894 |
| 2025-08-1411:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-005405 |
| 2025-07-1511:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-159017 |
| 2025-07-1411:45 ET | 8-K | 8.01 Other events | 0000950170-25-095460 |
| 2025-06-1820:10 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-087888 |
| 2025-05-1520:45 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-072789 |
| 2025-05-1511:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-003207 |
| 2025-04-3020:08 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0000950170-25-061041 |
| 2025-03-1821:03 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-041379 |
| 2025-03-1811:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-001513 |
| 2025-01-2121:52 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-009595 |
| 2024-12-2021:17 ET | DEF 14A | Proxy statementPeriod 2025-01-17 | 0001140361-24-050096 |
| 2024-11-1421:05 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-127033 |
| 2024-11-1412:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-006360 |
| 2024-10-3113:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-119270 |
| 2024-10-1820:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-115596 |
| 2024-09-1320:05 ET | 8-K | 3.01 Delisting notice | 0000950170-24-106345 |
| 2024-08-3020:05 ET | 8-K | 3.01 Delisting notice | 0000950170-24-102321 |
| 2024-08-1320:03 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-096142 |
| 2024-08-1311:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-004721 |
| 2024-06-1720:05 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-074233 |
| 2024-05-1612:02 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity | 0000950170-24-060805 |
| 2024-05-1411:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-002826 |
| 2024-05-1411:28 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-059081 |
| 2024-04-2921:25 ET | DEF 14A | Proxy statementPeriod 2023-12-31 | 0000950170-24-050064 |
| 2024-03-2120:05 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-034672 |
| 2024-03-2111:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-001514 |
| 2024-02-2921:05 ET | 8-K | 3.01 Delisting notice | 0000950170-24-023061 |
| 2024-02-1423:05 ET | SC 13D | Ownership report, active investor | 0001193125-24-036660 |
| 2024-02-1413:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0000950170-24-014944 |
| 2023-11-1422:17 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-063851 |
| 2023-11-0912:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-006910 |
| 2023-10-1720:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-23-053752 |
| 2023-08-1011:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-005189 |
| 2023-08-1011:26 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-040958 |
| 2023-06-2019:45 ET | 8-K | 5.07 Shareholder vote results | 0000950170-23-028900 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.